Aspen API. More than just an API™
Reset all filters
01 18Aspen API
02 7Aspen Pharmacare Holdings
03 4Dr. Reddy's Laboratories
04 4Aurobindo Pharma Limited
05 1BrightGene Bio-Medical Technology Co.,Ltd
06 2DR REDDY'S LABORATORIES LTD
07 1Farmak JSC
08 5GSK
09 4Hangzhou Zhongmei Huadong Pharmaceutical
10 8Jiangsu Hengrui Medicine
11 1Lotus Pharmaceutical Industries
12 4ScinoPharm Taiwan Ltd
13 19Viatris
14 4XYZ Pharma
Reset all filters
01 1Fondaparinux 1,5Mg 0,3Ml 10 Units Parenteral Use
02 1Fondaparinux 10Mg 0,8Ml 10 Units Parenteral Use
03 1Fondaparinux 2,5Mg 0,5Ml 10 Inita' Parenteral Use
04 1Fondaparinux 5Mg 0.4 Ml 10 Units Parenteral Use
05 1Fondaparinux 7,5Mg 0,6Ml 10 Units Parenteral Use
06 4INJ
07 25INJECTABLE;SUBCUTANEOUS
08 5Injectable Solution In Pre-Filled Syringe
09 9Injection
10 13Injection fluid, resolution
11 1Prefilled Syringe
12 4SOLUTION
13 15Solution For Injection
14 1Blank
Reset all filters
01 5Allowed
02 5Approved
03 5Authorized
04 4DISCN
05 5Deregistered
06 2Generic
07 4Lead Market Dossiers- Filed
08 3Originator
09 4Prescription
10 21RX
11 4US FDA Preapproval Inspection- Pass
12 20Blank
Reset all filters
01 6ARIXTRA
02 29Arixtra
03 5Arixtra
04 1Arixtra 10,0mg/0,8ml
05 1Arixtra 2,5 mg/0,5 ml
06 1Arixtra 5,0mg/0,4ml
07 1Arixtra 7,5mg/0,6ml
08 21FONDAPARINUX SODIUM
09 2FONDAPARINUX SODIUM INJECTION
10 1Product Under Development
11 5Quixidar
12 9Blank
Reset all filters
01 1Australia
02 4Canada
03 4China
04 1Egypt
05 4India
06 5Italy
07 13Norway
08 4South Africa
09 5Spain
10 10Sweden
11 5Switzerland
12 25USA
13 1Ukraine
Regulatory Info :
Registration Country : Italy
Brand Name : Arixtra
Dosage Form : Fondaparinux 1,5Mg 0,3Ml 10 Units Parenteral Use
Dosage Strength : 10 SYRINGES SC 1.5 mg 0.3 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : ARIXTRA
Dosage Form : SOLUTION
Dosage Strength : 2.5MG/0.5ML
Packaging : 0.5ML
Approval Date :
Application Number : 2245531
Regulatory Info : Prescription
Registration Country : Canada
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 2.5MG/0.5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info :
Registration Country : Italy
Brand Name : Arixtra
Dosage Form : Fondaparinux 10Mg 0,8Ml 10 Units Parenteral Use
Dosage Strength : 10 SYRINGES SC 10 mg 0.8 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Arixtra
Dosage Form : Fondaparinux 2,5Mg 0,5Ml 10 Inita' Parenteral Use
Dosage Strength : 10 SYRINGES SC 2.5 mg 0.5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Arixtra
Dosage Form : Fondaparinux 5Mg 0.4 Ml 10 Units Parenteral Use
Dosage Strength : 10 SYRINGES SC 5 mg 0.4 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Arixtra
Dosage Form : Fondaparinux 7,5Mg 0,6Ml 10 Units Parenteral Use
Dosage Strength : 10 SYRINGES SC 7.5 mg 0.6 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Arixtra
Dosage Form : Injection fluid, resolution
Dosage Strength : 10 mg/0.8 ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Arixtra
Dosage Form : Injection fluid, resolution
Dosage Strength : 10 mg/0.8 ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Arixtra
Dosage Form : Injection fluid, resolution
Dosage Strength : 10 mg/0.8 ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Arixtra
Dosage Form : Injection fluid, resolution
Dosage Strength : 2.5 mg/0.5 ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Arixtra
Dosage Form : Injection fluid, resolution
Dosage Strength : 2.5 mg/0.5 ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Arixtra
Dosage Form : Injection fluid, resolution
Dosage Strength : 2.5 mg/0.5 ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Arixtra
Dosage Form : Injection fluid, resolution
Dosage Strength : 2.5 mg/0.5 ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Arixtra
Dosage Form : Injection fluid, resolution
Dosage Strength : 5 mg/0.4 ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Arixtra
Dosage Form : Injection fluid, resolution
Dosage Strength : 5 mg/0.4 ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Arixtra
Dosage Form : Injection fluid, resolution
Dosage Strength : 5 mg/0.4 ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Arixtra
Dosage Form : Injection fluid, resolution
Dosage Strength : 7.5 mg/0.6 ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Arixtra
Dosage Form : Injection fluid, resolution
Dosage Strength : 7.5 mg/0.6 ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Arixtra
Dosage Form : Injection fluid, resolution
Dosage Strength : 7.5 mg/0.6 ml
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway